Pharmacotherapy in clinical trials for abdominal aortic aneurysms: A systematic review and meta-analysis

Z Su, J Guo, Y Gu - Clinical and Applied Thrombosis …, 2022 - journals.sagepub.com
Objective There is no medical treatment proven to limit abdominal aortic aneurysm (AAA)
progression. This systematic review aimed to summarise available trial evidence on the …

Research advances in drug therapy for abdominal aortic aneurysms over the past five years: An updated narrative review

R Li, Y Liu, J Jiang - International Journal of Cardiology, 2023 - Elsevier
Background Abdominal aortic aneurysms (AAA) rupture can lead to patient death. Surgical
treatment is currently the optimal treatment for AAA with large diameter (≥ 50 mm). For AAA …

Standardization of outcome measures in clinical trials of pharmacological treatment for abdominal aortic aneurysm

XL Wang, MM Thompson, WP Dole… - Expert review of …, 2012 - Taylor & Francis
An abdominal aortic aneurysm (AAA) is a common aortic wall disease with an increased
prevalence in the elderly population (4–8% for those aged> 65 years). Many AAAs are slow …

Pathogenesis and management of abdominal aortic aneurysm

J Golledge, S Thanigaimani, JT Powell… - European Heart …, 2023 - academic.oup.com
Abdominal aortic aneurysm (AAA) causes∼ 170 000 deaths annually worldwide. Most
guidelines recommend asymptomatic small AAAs (30 to< 50 mm in women; 30 to< 55 mm in …

Current status and perspectives on pharmacologic therapy for abdominal aortic aneurysm

K Yoshimura, N Morikage… - Current drug …, 2018 - ingentaconnect.com
Background: Abdominal aortic aneurysm (AAA), a common disease involving the segmental
expansion and rupture of the aorta, has a high mortality rate. Therapeutic options for AAA …

Pharmacological therapy for patients with abdominal aortic aneurysm

AN Assar - Expert review of cardiovascular therapy, 2009 - Taylor & Francis
Abdominal aortic aneurysm (AAA) is a common and life-threatening disease characterized
by progressive dilatation and rupture, and has a mortality rate of up to 90%. Surgical repair …

Current status of medical treatment for abdominal aortic aneurysm

K Kurosawa, JS Matsumura, D Yamanouchi - Circulation Journal, 2013 - jstage.jst.go.jp
2861 Medical Treatment for Abdominal Aortic Aneurysm ical treatments include anti-
hypertensives, statins, and antibiotics, some of which might work as MMP inhibitors. Tables …

Effect of blood pressure lowering drugs and antibiotics on abdominal aortic aneurysm growth: a systematic review and meta-analysis

J Golledge, TP Singh - Heart, 2021 - heart.bmj.com
Objective There is currently no medical treatment proven to limit abdominal aortic aneurysm
(AAA) progression. The aim of this systematic review and meta-analysis was to pool data …

[HTML][HTML] Editor's Choice–pharmaceutical management of small abdominal aortic aneurysms: a systematic review of the clinical evidence

VBC Kokje, JF Hamming, JHN Lindeman - European Journal of Vascular …, 2015 - Elsevier
Background Management of abdominal aortic aneurysms (AAAs) relies on surgical repair of
larger AAAs. Consequently medical interventions inhibiting AAA progression could greatly …

[HTML][HTML] Editor's Choice–Association between metformin prescription and abdominal aortic aneurysm growth and clinical events: a systematic review and meta …

S Thanigaimani, TP Singh, J Unosson, J Phie… - European Journal of …, 2021 - Elsevier
Objective A meta-analysis of the association between metformin prescription and abdominal
aortic aneurysm (AAA) growth and events (rupture or surgical repair) was performed …